28 29 Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr. Effect of selenium and vita- min E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51. [190 66370] [http://dx.doi.org/10.1001/ ja- ma.2008.864] Agarwal P, Griffith A, Costantino HR, Vaish N. Gabapentin enacarbil - clinical efficacy in restless legs syn- drome. Neuropsychiatr Dis Treat 2010;6:151-8. [20505847] [http://dx. doi.org/10.2147/NDT.S5712] Högl B, Oertel WH, Stiasny-Kolster 30 K, Geisler P, Beneš H, García- Borreguero D, Trenkwalder C, Poe- we W, Schollmayer E, Kohnen R. Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch. BMC Neurol 2010;10:86. [20920156] [http://dx.doi.org/10.11 86/1471-2377-10-86] Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K; TREAT RLS 2 (Therapy with Ropinirole: Ef- ficacy And Tolerability in RLS 2) Study Group. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12- week, double-blind, randomized, parallel-group, placebo-controlled Selenium in restless leg syndrome study. Mov Disord 2004;19:1414-23. [15390050] [http://dx.doi.org/10.100 2/mds.20257] 31 Aizawa H, Aburakawa Y, Suzuki Y, Enomoto H, Makita Y, Kikuchi K, Kimura T, Yahara O. Treatment of Japanese restless legs syndrome patients with cabergoline. Intern Med 2006;45:453-5. [16679700] [http://dx.doi.org/10.2169/internalme dicine.45.1555] 32 Fulda S, Wetter TC. Where dopa- mine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies. Brain 2008;131:902-17. [17932100] [http:// dx.doi.org/10.1093/brain/awm244] WWW.ircmj.com Vol 14 January 2012 19